Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. (Q38186634)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on June 2014

Language	Label	Description	Also known as
English	Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.	scientific article published on June 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Benjamin Thierry

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Kisha Nandini Sivanathan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Darling Rojas-Canales

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

P Toby Coates

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Stem Cell Reviews and Reports

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

351-375

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Effector mechanisms in transplant rejection

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Dendritic cells: specialized and regulated antigen processing machines

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Pathways of allorecognition: implications for transplantation tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

The role of T-cell costimulatory activation pathways in transplant rejection

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Pathways of major histocompatibility complex allorecognition.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

T-cell costimulatory pathways in allograft rejection and tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Costimulatory pathways in transplantation: challenges and new developments.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Models of T cell anergy: is there a common molecular mechanism?

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mechanisms of rejection: current perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Humoral autoimmunity and transplant vasculopathy: when allo is not enough

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Immunsuppressiva - Wirkungen, Nebenwirkungen und Interaktionen

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Role of mesenchymal stromal cells in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

More insight into mesenchymal stem cells and their effects inside the body

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells as trophic mediators

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Role of injured pancreatic extract promotes bone marrow-derived mesenchymal stem cells efficiently differentiate into insulin-producing cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells in kidney inflammation and repair

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

The immunosuppressive effect of embryonic stem cells and mesenchymal stem cells on both primary and secondary alloimmune responses

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

CD200/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; Part I: CD200/CD200R structure, activation, and function.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Retracted: Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Interactions between mesenchymal stem cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells negatively regulate dendritic lineage commitment of umbilical-cord-blood-derived hematopoietic stem cells: an unappreciated mechanism as immunomodulators

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells avoid allogeneic rejection

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cell therapy: Two steps forward, one step back

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Immunogenicity of allogeneic mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Immunological aspects of allogeneic mesenchymal stem cell therapies

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Immunomodulatory properties of human periodontal ligament stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Activated mesenchymal stem cells increase wound tensile strength in aged mouse model via macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Potential risks of bone marrow cell transplantation into infarcted hearts

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9495-2

21 January 2018

Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of chemokines in the regulation of dendritic cell trafficking

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The B-cell response to protein antigens in immunity and transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraportal injection of insulin-producing cells generated from human bone marrow mesenchymal stem cells decreases blood glucose level in diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor resident mesenchymal stromal cells endow naïve stromal cells with tumor-promoting properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Inhibitory effect of mesenchymal stem cells carrying murine beta defensin 2 on malignant ascites in mice]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stem cells and rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A method for induction of mouse CD8α(+);CD11b(+);jagged2(high);regulatory dendritic cells with mesenchymal stem cells in vitro].

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Investigation of the role of mesenchymal stem cells on keratoplasty rejection]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stromal cells impair the differentiation of CD14(++) CD16(-) CD64(+) classical monocytes into CD14(++) CD16(+) CD64(++) activate monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute renal allograft rejection: progress in understanding cellular and molecular mechanisms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510581

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12015-014-9495-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510581%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38186634&oldid=2201380004"